Canada · Delayed Price · Currency is CAD Verde AgriTech Earnings Call Transcripts
Fiscal Year 2026
-
A new CEO with deep agribusiness and engineering expertise is taking the helm, focusing on large-scale growth, product advantages over potassium chloride, and ESG initiatives like carbon capture. Plans are advancing to spin off the rare earths project, aiming for two independent, focused companies.
-
The event highlighted progress in rare earths exploration, with high concentrations of key magnetic elements and a clear timeline for resource validation and economic assessment this year. The fertilizer business faces market headwinds but offers sustainability advantages and long-term potential.
Fiscal Year 2025
-
Positive EBITDA achieved for the first time in over two years, despite a year-over-year decline in sales and revenue. Cost controls, reduced bad debt, and new patents support optimism for sector recovery and future growth, with significant potential in ERW and rare earths.
-
Q2 2025 saw stable product volumes and improved gross margins despite Brazil's ag crisis. Debt was successfully restructured, reducing short-term obligations and enhancing liquidity, while cost reductions and AI integration supported operational efficiency.
-
Directors and auditors were re-elected, financial statements for 2024 were approved, and authority to issue shares was granted. All resolutions passed with strong shareholder support, and director fees for 2025 were set.
-
Q1 2025 saw a 44% drop in sales and revenue amid Brazil's agricultural crisis, but cost reductions, improved gross margins, and a major debt restructuring have strengthened liquidity and positioned the company for recovery as market conditions improve.
-
The merger creates a major rare earths player in Brazil, combining large, high-grade resources and experienced leadership. The project targets global supply diversification, with strong investor interest, government support, and a clear path to production in 3–4 years.
Fiscal Year 2024
-
Leadership overhaul and cost reductions followed a tough year, with 2024 revenue down 43% and net loss doubling. Early 2025 sales and orders already reach 60% of last year's total, signaling a strong turnaround and cautious optimism for the second half of 2025.
-
The meeting confirmed quorum and proceeded to vote on two key resolutions: appointing auditors and reducing share capital by distributing Oby Rare Earths Pty Ltd shares. Both resolutions passed with overwhelming shareholder support.
-
Q3 2024 saw lower sales and revenue but improved EBITDA and reduced net loss due to cost cuts. The company is managing high credit risk in Brazilian agriculture, focusing on debt restructuring, cost control, and developing new markets, while preparing a rare earths spin-off.
-
Q2 2024 saw lower sales volumes and revenue, with a net loss and reduced margins amid challenging market and credit conditions. Debt restructuring is underway, and a new sales team and product focus are expected to drive future growth.
-
The AGM addressed board changes, approved all resolutions, and highlighted strong operational capacity, strategic focus on carbon technologies, and a new sales approach. Despite market challenges, the company is positioned for growth and innovation.